Bonadio RR da CC, Tavares M, Rosa DD, Brito ML de, Gagliato D de M, Suzuki DA, et al. Dose-dense versus 3-weekly ac during neoadjuvant chemoimmunotherapy for early-stage triple-negative breast cancer: GBECAM 0123 – the neo-real study. MAST [Internet]. 2026 Mar. 5 [cited 2026 May 1];34(suppl. 1). Available from: https://mastology.org/journal/article/view/1430